Latest period
$903M
YoY change
+7.1%
5Y CAGR
+6.8%
Peak year (FY2025)
$894M
Latest annual
$894M
Stock-Based Compensation history chart for Gilead Sciences (GILD) from 2016 to 2025
Latest: $894M
Stock-Based Compensation growth chart for Gilead Sciences (GILD) from 2016 to 2025
Latest: +7.1%
Stock-Based Compensation history table for Gilead Sciences (GILD) from 1990 to 2025
| FY2025 | $894M | +7.1% | +$59M | ||
| FY2024 | $835M | +9.0% | +$69M | ||
| FY2023 | $766M | +18.9% | +$122M | ||
| FY2022 | $644M | +1.4% | +$9M | ||
| FY2021 | $635M | -1.2% | -$8M | ||
| FY2020 | $643M | +1.1% | +$7M | ||
| FY2019 | $636M | -24.7% | -$209M | ||
| FY2018 | $845M | +32.4% | +$207M | ||
| FY2017 | $638M | +67.9% | +$258M | ||
| FY2016 | $380M | -0.5% | -$2M | ||
| FY2015 | $382M | +6.1% | +$22M | ||
| FY2014 | $360M | +42.9% | +$108M | ||
| FY2013 | $252M | +20.6% | +$43M | ||
| FY2012 | $209M | +8.6% | +$16.6M | ||
| FY2011 | $192M | -3.8% | -$7.66M | ||
| FY2010 | $200M | +10.7% | +$19.4M | ||
| FY2009 | $181M | +17.8% | +$27.3M | ||
| FY2008 | $153M | — | +$153M | ||
| FY2007 | $0.00 | — | $0.00 | ||
| FY2006 | $0.00 | — | $0.00 | ||
| FY2005 | $0.00 | — | $0.00 | ||
| FY2004 | $0.00 | — | $0.00 | ||
| FY2003 | $0.00 | — | $0.00 | ||
| FY2002 | $0.00 | — | $0.00 | ||
| FY2001 | $0.00 | — | $0.00 | ||
| FY2000 | $0.00 | — | $0.00 | ||
| FY1999 | $0.00 | — | $0.00 | ||
| FY1998 | $0.00 | — | $0.00 | ||
| FY1997 | $0.00 | — | $0.00 | ||
| FY1996 | $0.00 | — | $0.00 | ||
| FY1995 | $0.00 | — | $0.00 | ||
| FY1994 | $0.00 | — | — | ||
| FY1992 | $0.00 | — | $0.00 | ||
| FY1991 | $0.00 | — | $0.00 | ||
| FY1990 | $0.00 | — | — |
- FY2025$894M+7.1%
- FY2024$835M+9.0%
- FY2023$766M+18.9%
- FY2022$644M+1.4%
- FY2021$635M-1.2%
- FY2020$643M+1.1%
- FY2019$636M-24.7%
- FY2018$845M+32.4%
- FY2017$638M+67.9%
- FY2016$380M-0.5%
- FY2015$382M+6.1%
- FY2014$360M+42.9%
- FY2013$252M+20.6%
- FY2012$209M+8.6%
- FY2011$192M-3.8%
- FY2010$200M+10.7%
- FY2009$181M+17.8%
- FY2008$153M—
- FY2007$0.00—
- FY2006$0.00—
- FY2005$0.00—
- FY2004$0.00—
- FY2003$0.00—
- FY2002$0.00—
- FY2001$0.00—
- FY2000$0.00—
- FY1999$0.00—
- FY1998$0.00—
- FY1997$0.00—
- FY1996$0.00—
- FY1995$0.00—
- FY1994$0.00—
- FY1992$0.00—
- FY1991$0.00—
- FY1990$0.00—
Stock-Based Compensation values are taken from Gilead Sciences's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at Gilead Sciences (GILD)
Stock-Based Compensation for Gilead Sciences (GILD): headline value $903M · YoY +7.1%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Gilead Sciences (GILD) stock-based compensation totalled $894M – grew 7.1% year-over-year.
Gilead Sciences stock-based compensation has grown on net over the period, with a +6.8% compound annual growth rate over 2020–2025 (5 years).
$894M stands as the all-time-high annual stock-based compensation, posted in 2025, against a low of $0.00 during 1990.
Gilead Sciences Stock-Based Compensation by Year
Gilead Sciences Stock-Based Compensation 2025: $894M
2025's stock-based compensation for Gilead Sciences came in at $894M, grew 7.1% from 2024. This figure represents the highest annual value in the available history.
Gilead Sciences Stock-Based Compensation 2024: $835M
Gilead Sciences posted stock-based compensation of $835M in 2024, grew 9.0% from 2023.
Gilead Sciences Stock-Based Compensation 2023: $766M
In 2023, Gilead Sciences reported stock-based compensation of $766M, grew 18.9% from 2022.
Gilead Sciences Stock-Based Compensation 2022: $644M
Gilead Sciences stock-based compensation in 2022 was $644M, edged up 1.4% from 2021.
Gilead Sciences Stock-Based Compensation 2021: $635M
Gilead Sciences stock-based compensation in 2021 was $635M.
See more financial history for Gilead Sciences (GILD).
Sector peers by Stock-Based Compensation
Healthcare peers of Gilead Sciences (GILD), ranked by their latest stock-based compensation
| $1.35B | |
| $971M | |
| $955M | |
| $626M | |
| $494M | |
| $310M | |
| $0.00 | |
| $0.00 |
- $1.35B
- $955M
- $626M
- $494M
- $0.00
- $0.00
Frequently asked questions
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.93% TTM
- Dividend Profile2.43% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History5 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.